Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $13.58M.
ENTERPRISE VALUE (EV)
$13.58M
BioCardia, Inc.
Market Cap
$16.08M
Enterprise Value (EV)
$13.58M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| BioCardia, Inc. (BCDA) | $16.08M | $13.58M |
| Bionano Genomics, Inc. (BNGO)vs › | $16.74M | $19.71M |
| Dyadic International, Inc. (DYAI)vs › | $16.87M | $20.49M |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | $21.06M |
| Lipocine Inc. (LPCN)vs › | $17.19M | $12.21M |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.44M | $14.61M |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.39M | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.18M | $176.09M |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.76M | $6.43M |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.14M | $4.31M |
Market Cap
$16.08M
Total Debt
$0.00
Cash
$2.50M
Enterprise Value
$13.58M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
